Nuclera

Nuclera, headquartered in Boston, Massachusetts, is a biotechnology company dedicated to advancing scientific research. Founded in 2013, Nuclera boasts a team of over 100 employees and operates internationally with a presence in Cambridge, UK. Nuclera specializes in providing researchers with rapid access to high-quality, soluble, active proteins. Their flagship product, the eProtein Discovery™ system, automates the screening process for optimal protein expression and purification, yielding results within 24 hours. This innovative technology enables researchers to accelerate their protein projects, significantly reducing the time required to obtain reliable protein samples. Nuclera's approach integrates cell-free protein synthesis and digital microfluidics, offering a benchtop, automated, and high-throughput solution. Their smart cartridges streamline protein production, allowing researchers to scale-up protein quantities to milligrams in as little as 48 hours. Visit Nuclera's website at www.nuclera.com for more information.